Matisse Pharmaceuticals

Heparin based therapeutics for severe sepsis and septic shock.

placeGeleen, Limburg, Netherlands calendar_todayFounded 2014 language matisse-pharma.com

Social engagement

Social engagement: 798 social following, 4 posts in the last 12 months — top 10% of its industry.

Investor mix

3 investors on record; lead investors include Brightlands Venture Partners.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%

Recent activity

19 May 2026
Milestone
regulatory
11 Dec 2025
Recognition
Coming soon